Intracoronary Use of GP IIb/IIIa Inhibitors in Percutaneous Coronary Interventions

By  

Current Vascular Pharmacology, Vol. 10, Iss. 4, 2012-07 ,pp. : 448-453

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?

By  

Current Cardiology Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 84-91

Bentham Science Publishers

Access to resources Recommend Favorite

Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the national registry of myocardial infarction 4

By Peterson E.D.   Pollack C.V.   Roe M.T.   for the National Registry of Myocardial Infarction NRMI 4 Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 15-15

Elsevier

Access to resources Recommend Favorite

GP IIb/IIIa Inhibitors for STEMI: Still the Gold Standard or an Old Survivor?

By  

Current Vascular Pharmacology, Vol. 10, Iss. 4, 2012-07 ,pp. : 443-447

Bentham Science Publishers

Access to resources Recommend Favorite

Use of glycoprotein IIb/IIIa receptor antagonist in prosthetic valve thrombosis

By Caceres-Loriga F.   Santos-Gracia J.  

Platelets, Vol. 21, Iss. 7, 2010-11 ,pp. : 583-583

Informa Healthcare

Access to resources Recommend Favorite